Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Int J Epidemiol. 2012 Apr;41(2):472-81. doi: 10.1093/ije/dyr208. Epub 2012 Jan 31.
In China, there have been few large prospective studies of the associations of body mass index (BMI) with overall and cause-specific mortality that have simultaneously controlled for biases that can be caused by pre-existing disease and smoking.
Prospective cohort study of 224 064 men, of whom 40 700 died during follow-up between 1990-91 and 2006. Analyses restricted to 142 214 men aged 40-79 years at baseline with no disease history and, to further reduce bias from pre-existing disease, at least 5 years of subsequent follow-up, leaving 17 800 deaths [including 4165 stroke, 1297 coronary heart disease (CHD), 3121 chronic obstructive pulmonary disease (COPD)]. Adjusted hazard ratios (HRs) and 95% confidence intervals (95% CIs) per 5 kg/m(2) calculated within either a lower (15 to <23.5 kg/m(2)) or higher (23.5 to <35 kg/m(2)) range.
The association between BMI and all-cause mortality was U-shaped with the lowest mortality at ∼22.5-25 kg/m(2). In the lower range, 5 kg/m(2) higher BMI was associated with 14% lower mortality (HR 0.86, 95% CI 0.82-0.91); in the upper range, it was associated with 27% higher mortality (HR 1.27, 95% CI 1.15-1.40). The absolute excess mortality in the lower range was largely accounted for by excess mortality from specific smoking-related diseases: 54% by that for COPD, 12% other respiratory disease, 13% lung cancer, 11% stomach cancer. The excess mortality in the upper BMI range was largely accounted for by excess mortality from specific vascular diseases: 55% by that for stroke, 16% CHD. In this range, 5 kg/m(2) higher BMI was associated with ∼50% higher mortality from stroke (HR 1.61, 95% CI 1.36-1.92) and CHD (HR 1.48, 95% CI 1.12-1.95).
For China, previous evidence may have overestimated the excess mortality at low BMI but underestimated that at high BMI. The main way obesity kills in China appears to be stroke.
在中国,很少有大型前瞻性研究同时控制由既往疾病和吸烟引起的偏倚,以探讨体质指数(BMI)与全因和死因特异性死亡率的关系。
对 224064 名男性进行前瞻性队列研究,其中 40700 名男性在 1990-91 年至 2006 年随访期间死亡。分析仅限于基线时年龄在 40-79 岁、无疾病史的 142214 名男性,为进一步减少既往疾病引起的偏倚,至少有 5 年的后续随访,共发生 17800 例死亡[包括 4165 例卒中、1297 例冠心病(CHD)、3121 例慢性阻塞性肺疾病(COPD)]。按每 5kg/m2 计算的调整后风险比(HR)和 95%置信区间(95%CI),分别在较低(15 至 <23.5 kg/m2)或较高(23.5 至 <35 kg/m2)范围内。
BMI 与全因死亡率呈 U 型关系,在 22.5-25kg/m2 左右死亡率最低。在较低范围内,BMI 每增加 5kg/m2,死亡率降低 14%(HR 0.86,95%CI 0.82-0.91);在较高范围内,死亡率升高 27%(HR 1.27,95%CI 1.15-1.40)。较低范围内的绝对超额死亡率主要归因于与特定吸烟相关疾病的死亡率过高:54%归因于 COPD,12%归因于其他呼吸系统疾病,13%归因于肺癌,11%归因于胃癌。较高 BMI 范围内的超额死亡率主要归因于特定血管疾病的死亡率过高:55%归因于卒中,16%归因于 CHD。在这一范围内,BMI 每增加 5kg/m2,卒中(HR 1.61,95%CI 1.36-1.92)和 CHD(HR 1.48,95%CI 1.12-1.95)的死亡率约增加 50%。
对于中国来说,既往的证据可能高估了低 BMI 人群的超额死亡率,但低估了高 BMI 人群的超额死亡率。肥胖在中国导致死亡的主要方式似乎是卒中。